Weinberg, M. A. (2016). RES-529: A PI3K/AKT/mTOR pathway inhibitor that dissociates the mTORC1 and mTORC2 complexes. Anticancer Drugs.
Citação norma ChicagoWeinberg, Mark A. "RES-529: A PI3K/AKT/mTOR Pathway Inhibitor That Dissociates the MTORC1 and MTORC2 Complexes." Anticancer Drugs 2016.
MLA citiranjeWeinberg, Mark A. "RES-529: A PI3K/AKT/mTOR Pathway Inhibitor That Dissociates the MTORC1 and MTORC2 Complexes." Anticancer Drugs 2016.
Opozorilo: Ti citati niso vedno 100% točni.